Joel Ackerman - 01 Nov 2022 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Reporting relationship: Director
Issuer ticker: CSBR
Reported as of: 01 Nov 2022
Net transaction value: +$185,500
SEC form: 4
Accepted by SEC: 17 Aug 2023, 12:10:05 UTC
Prior SEC filing: 20 Oct 2022
Next SEC filing: 27 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Joel Ackerman

Key filing fact

Joel Ackerman filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 17 Aug 2023.

Key facts

This page summarizes Joel Ackerman's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Aug 2023, 12:10.

Change

Previous filing in this sequence was filed on 20 Oct 2022.
Current net transaction value: +$185,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSBR transaction Derivative

Option to purchase Common Stock

Award

Transaction value: $185,500
Shares: +26,500
Change %
Price: $7.00
Shares after: 26,500
Date: 01 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,500
Exercise price: $7.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1, 2023, respectively.